Frontlight ResearchEarly access
CompletedNo phase
Genicular Artery Embolization to Reduce Pain Associated With Unilateral Mild to Moderate Osteoarthritis
Key facts
- Who runs it
- University of Chicago
- Where
- Chicago, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 5 people enrolled
- Started
- 22 Sept 2021
- Ended
- 28 May 2024
- Type of study
- Interventional
- Treatments tested
- the Terumo Hydropearl® microspheres device
- Record updated
- 4 November 2024
Who can take part
- Age
- 40 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- We intend to include patients who meet the following criteria in the study:
- Patients aged 40-80
- Bilateral or Unilateral knee pain attributed to osteoarthritis
- Grade 1-3 Osteoarthritis as diagnosed on standing weight-bearing knee radiographs per the Kellen-Lawrence Grading scale
- Knee pain >6 months refractory to conservative medical management (NSAIDs, paracetamol, intra-articular injections, physiotherapy/exercise, weight loss, etc.)
Who cannot take part
- We plan to exclude patients who meet any of the following criteria:; Active malignancy; Active infection of the affected knee; Platelets <50,000; INR >1.8 (unless on anticoagulation that can be reversed); Corticosteroid injection of the affected knee within 3 months; Rheumatoid arthritis or other seronegative arthropathy; Previous surgery (excluding arthroscopy) of the affected knee; Grade 4 per Kellgren-Lawrence Grading Scale of the affected knee; Pregnancy or expected pregnancy; GFR <30; Anaphylactic reaction to iodinated contrast; Moderate to severe pain in other lower limb joints; Body weight >400 lbs. (Procedure table weight limit); BMI >50; Patients at high risk for contrast nephropathy
Where in United States
- University of Chicago HospitalChicago, United States
About the trial
What the trial wants to find out
The goal of this study is to perform a feasibility study to show the effectiveness of the genicular artery embolization procedure in reducing bilateral or unilateral osteoarthritic knee pain at 12 months as measured by WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) score, Knee Injury and Osteoarthritis Outcome (KOOS) score, and Oswestry Disability Index.
The group in the trial
- GAE ArmTreatment being tested
Patients who meet study eligibility will be scheduled to undergo the Genicular Artery Embolization procedure and will subsequent be followed for 12 months after their procedure.
Treatment: the Terumo Hydropearl® microspheres device
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Genicular Artery Embolization to Reduce Pain Associated With Unilateral Mild to Moderate Osteoarthritis: A Pilot Study to Assess Feasibility
- Record updated
- 4 November 2024